# Shanghai Dingxin Gene Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-dingxin-gene-technology

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Latest round: Angel (Mar 29, 2021)
- Investors on record: 2

## About

Established in 2020 and based in Shanghai, China, Shanghai Dingxin Gene Technology is a gene technology developer that focuses on the development of gene therapy drugs and specific drugs. The core team has more than ten years of experience in biomedicine research and development and commercial transformation. The company's product mainly used in the field of ophthalmology, otology, cardiovascular, tumor and central nervous system (CNS). In 2021, the company has built a thousand square meters of gene therapy research and development center in Shanghai.

The company's provides technical consulting, technical services, technology development, technology transfer; health consulting services; information consulting services of gene technology, biotechnology and medical technology for customers.

The company's plan to use the pre-A funding to pre-clinical product development and AAV (adeno-associated virus) and non-viral delivery technology platform construction.

## Funding rounds

- Angel, Mar 29, 2021 — Kaili Yifang Capital Management, LC Ventures

## Investors

- Kaili Yifang Capital Management (https://capitalatlas.ai/funds/kaili-yifang-capital-management) — Angel
- LC Ventures (https://capitalatlas.ai/funds/lc-ventures) — Angel